Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New agents for prostate cancer.

D M Reese1

  • 1Department of Medicine, UCSF Comprehensive Cancer Center, University of California San Francisco, USA. dreese85@hotmail.com

Hematology/Oncology Clinics of North America
|August 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ship Fever at the Bellevue Hospital.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening Diseases.

Clinical pharmacology and therapeutics·2017
Same author

Third-generation aromatase inhibitors in the treatment of advanced breast cancer.

Breast cancer (Tokyo, Japan)·2002
Same author

Treatment options in hormone-refractory prostate cancer: current and future approaches.

Drugs·2002
Same author

Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.

Seminars in oncology·2001
Same author

HER2 protein expression and gene amplification in androgen-independent prostate cancer.

American journal of clinical pathology·2001
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

New biologic agents targeting molecular defects are crucial for advanced prostate cancer treatment. Research will focus on their efficacy, safety, and combination with chemotherapy or radiotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Development

Background:

  • Current treatments for advanced prostate cancer yield suboptimal outcomes.
  • There is a critical need for novel therapeutic strategies.

Purpose of the Study:

  • To explore the potential of next-generation biologic agents for advanced prostate cancer.
  • To investigate the efficacy and safety of novel targeted therapies.
  • To evaluate the combination of new agents with traditional treatments like chemotherapy and radiotherapy.

Main Methods:

  • Clinical research focusing on the development and evaluation of novel biologic agents.
  • Investigating targeted therapies aimed at specific molecular defects in cancer cells.
  • Assessing the safety and efficacy profiles of new treatment modalities.

Related Experiment Videos

Main Results:

  • The study outlines future research directions rather than presenting specific results.
  • Focus on the development pipeline for advanced prostate cancer therapies.

Conclusions:

  • Next-generation therapies, including novel biologic agents, hold promise for advanced prostate cancer.
  • Combination strategies involving targeted agents and traditional therapies are key research areas.